Control group:denosumab

2 trials

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai General Hospital

Conditions

Breast cancer with bone metastasisDysmobility Syndrome

Phase 4

A Multicenter Study Evaluating the Clinical Efficacy of Narusabumab versus Denosumab in Patients with Bone Metastases from Breast Cancer

Active, not recruitingChiCTR2600123763

Shanghai General HospitalBreast cancer with bone metastasis

Start: 2026-05-01Updated: 2026-05-04

Unknown Phase

A Real-World Study of Migu Capsules Combined with Denosumab in Treatment of Dysmobility Syndrome

Active, not recruitingChiCTR2400083781

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese MedicineDysmobility Syndrome

Start: 2024-05-01Updated: 2024-05-06